YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
1 Small-Cap Stock with Exciting Potential and 2 We Turn Down Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have…
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. Luckily f…
3 Healthcare Stocks We're Skeptical Of Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only risi…
On August 6, Artivion Inc. (NYSE:AORT) reported second-quarter 2026 results that read as if two different companies wrote them. Revenue for the quarter ended June 30 climbed 11% on a GAAP basis to $125.8 million, and the company finished a…
3 Profitable Stocks We Approach with Caution While profitability is essential, it doesn't guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, "Your margin…
3 Russell 2000 Stocks Walking a Fine Line Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, the…
Artivion stock has delivered a 57.6% gain over the past three years, yet current valuation checks suggest the shares now sit close to their estimated intrinsic value, rather than offering a clear discount. With the Discounted Cash Flow (DC…
1 High-Flying Stock to Own for Decades and 2 Facing Challenges Expensive stocks typically earn their valuations through superior growth rates that other companies simply can't match. The flip side though is that these lofty expectations ma…
Q2 Earnings Highlights: ICU Medical (NASDAQ:ICUI) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Let's dig into the relative performance of ICU Medical (NASDAQ:ICUI) and its peers as we unravel the n…
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chairman, President, and Chief Executive Officer - Pat MackinExecutive Vice President, Chief Operating Officer and Chief Financial Officer - Lance…
Key Points Interested in Artivion, Inc.? Here are five stocks we like better. Artivion's Q2 revenue rose 9% to $125.8 million on a constant-currency basis, driven by 12% growth in stent grafts and 18% growth in On-X valves. Adjusted EBITDA…
Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 In…
Steris (STE) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.54 per share. This compares to earnings of $2.34 per share a year ago. These figures are adjusted for non-recurring items. This qu…
3 Healthcare Stocks with Questionable Fundamentals From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial pe…
[Annual report under review] Willie B. Thomas In its Q2 portfolio update, Next Century Growth Investors disclosed nine new positions across three sectors. The industrial additions were Park Aerospace Corp. (PKE [https://seekingalpha.com/sy…
Fred Alger Management, an investment management company, released its "Alger Weatherbie Specialized Growth Fund" second-quarter 2026 investor letter. A copy of the letter can be downloaded here. U.S. equities experienced a strong recovery…
Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $2.8 per share, beating the Zacks Consensus Estimate of $2.48 per share. This compares to earnings of $2.19 per share a year ago. These figures are adjusted for non-recurr…
3 Stocks Under $50 with Warning Signs The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they're not immune to…
2 Growth Stocks Set to Flourishand 1 We Ignore Growth boosts valuation multiples, but it doesn't always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investor…
Artivion AORT recently secured FDA premarket approval ("PMA") for its AMDS Hybrid Prosthesis to treat acute DeBakey Type I aortic dissections with clinical or radiographic malperfusion. The approval removes the institutional review board (…
(RTTNews) - Artivion, Inc. (AORT), a medical device company, on Monday said the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for AMDS Hybrid Prosthesis, a device used to treat acute DeBakey Type I aortic dis…
3 Profitable Stocks We Keep Off Our Radar Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it will thrive tomorrow. Not al…
Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1 Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - card…
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Re…
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders The end of an earnings season can be a great time to discover new stocks and assess how companies are handli…
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek…
“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns whe…
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for…
Key Points Acquired 634,223 shares in Artivion; estimated trade size $25.02 million based on quarterly average price Quarter-end position value increased by $23.23 million, reflecting both share purchase and price movement Transaction valu…
On May 13, 2026, Yarger Wealth Strategies, LLC disclosed a new position in Artivion (NYSE:AORT), acquiring 634,223 shares in a trade estimated at $25.02 million based on quarterly average pricing. What happened According to a Securities an…
Artivion logo Key Points Interested in Artivion, Inc.? Here are five stocks we like better. Artivion reported double-digit first-quarter growth, with constant-currency revenue up 12% and adjusted EBITDA up 26% to $22.1 million, but it also…
Image source: The Motley Fool. Date May 7, 2026, 4:30 p.m. ET Call participants Chief Executive Officer — Pat Mackin Chief Operating Officer and Chief Financial Officer — Lance Berry Full Conference Call Transcript Unknown Speaker: Thank y…
Over the last six months, Artivion’s shares have sunk to $37.03, producing a disappointing 18.2% loss - a stark contrast to the S&P 500’s 3.9% gain. This was partly due to its softer quarterly results and may have investors wondering how t…
Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The first quarter of 2026 began with optimism about the domestic economy and attractive…
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some hav…
Artivion, Inc. AORT recently announced that the FDA has approved the premarket approval application for the NEXUS Aortic Arch System. Developed in partnership with Endospan Ltd., this innovative device targets aortic arch disease, one of t…